K2M Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 25-06-2024
- Paid Up Capital ₹ 0.10 M
as on 25-06-2024
- Company Age 7 Year, 23 Days
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 2.70 Cr
as on 25-06-2024
- Revenue -13.43%
(FY 2021)
- Profit 19.43%
(FY 2021)
- Ebitda 94.72%
(FY 2021)
- Net Worth -48.66%
(FY 2021)
- Total Assets -14.50%
(FY 2021)
About K2M Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹2.70 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kailash Chandra, Gaurav Dubey, Konarak Dubey, and Two other members serve as directors at the Company.
- CIN/LLPIN
U93090DL2017PTC327374
- Company No.
327374
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Dec 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at K2M Diagnostics?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kailash Chandra  | Director | 01-Jan-2018 | Current |
| Gaurav Dubey | Director | 25-Jun-2021 | Current |
| Konarak Dubey | Director | 19-Dec-2017 | Current |
| Mudrika Gaur | Director | 19-Dec-2017 | Current |
| Rajesh Varshney | Director | 01-Jan-2018 | Current |
Financial Performance of K2M Diagnostics.
K2M Diagnostics Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 13.43% decrease. The company also saw a substantial improvement in profitability, with a 19.43% increase in profit. The company's net worth observed a substantial decline by a decrease of 48.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of K2M Diagnostics?
In 2021, K2M Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Earthview Infratech Private LimitedActive 9 years 10 monthsKailash Chandra and Rajesh Varshney are mutual person
- Eco Con Technologies Private LimitedActive 8 years 10 months
Kailash Chandra and Rajesh Varshney are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 May 2018 | ₹2.70 Cr | Satisfied |
How Many Employees Work at K2M Diagnostics?
Unlock and access historical data on people associated with K2M Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of K2M Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped K2M Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
